Covid

Dosing intervals for COVID-19 mRNA Vaccine

Jan 14, 2021 | Beth Hess

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States. The portion regarding dosing intervals is summarized below:

  • Routine Scheduling. Do not schedule people to receive dose #2 earlier than recommended (i.e., 21 days for Pfizer-BioNTech or 28 days for Moderna).
  • Inadvertent Early Doses. Dose #2 inadvertently administered as much as 4 days too early (“grace period”) should be considered valid.
  • No Maximum Interval. There is no maximum interval between dose #1 and dose #2 for either vaccine. If dose #2 is administered beyond 21 or 28 days, there is no need to restart the series or repeat the dose.
  • Errors. Vaccine administration errors should be reported to the Vaccine Adverse Event Reporting System (VAERS).

Visit CDC’s COVID-19 Vaccination: Clinical Considerations gateway page for more information.


About Beth Hess

More posts by Beth Hess

Related Posts

Drugs
  • Press Release

After 50 Years, NACCHO Calls for an End to the War on...

The War on Drugs was declared on June 17, 1971, expanding the federal...

Jun 17, 2021 | Theresa Spinner

After 50 Years, NACCHO Calls for an End to the War on...

  • HIV, STI, & Viral Hepatitis

We’re Hiring! Join NACCHO’s HSH Team As a New Program...

NACCHO’s HIV, STI, Viral Hepatitis, and Harm Reduction team is hiring a Program...

Jun 11, 2021 | Shalesha Majors

We’re Hiring! Join NACCHO’s HSH Team As a New Program...

  • HIV, STI, & Viral Hepatitis

White House Appoints Harold Phillips to Lead Office of...

The White House announced the appointment of Harold Phillips to lead the...

Jun 11, 2021 | Shalesha Majors

White House Appoints Harold Phillips to Lead Office of...

Logo AHEAD
  • HIV, STI, & Viral Hepatitis

HHS Updated America’s HIV Epidemic Analysis Dashboard...

HHS updated AHEAD with new data for all 6 EHE indicators at the national,...

Jun 11, 2021 | Shalesha Majors

HHS Updated America’s HIV Epidemic Analysis Dashboard...

  • COVID-19
  • HIV, STI, & Viral Hepatitis

How COVID-19 Altered HIV Care, PrEP Use, and Sexual...

This study adds to a research trend showing COVID-19’s significant impact on...

Jun 11, 2021 | Shalesha Majors

How COVID-19 Altered HIV Care, PrEP Use, and Sexual...

  • HIV, STI, & Viral Hepatitis

STI Express Services: Increasing Access and Testing...

This brief summarizes the results of the STI Express Initiative and highlights...

Jun 11, 2021 | Shalesha Majors

STI Express Services: Increasing Access and Testing...

Cdc badge small
  • HIV, STI, & Viral Hepatitis

CDC DIS Workforce Development Funding

The CDC Division of STD Prevention just launched a website dedicated to the...

Jun 11, 2021 | Shalesha Majors

CDC DIS Workforce Development Funding

  • HIV, STI, & Viral Hepatitis

CDC/NCSD Quarterly National Internet Partner Services...

Disease Intervention Specialists (DIS) serve as a cornerstone of the STD field...

Jun 11, 2021 | Shalesha Majors

CDC/NCSD Quarterly National Internet Partner Services...

  • HIV, STI, & Viral Hepatitis

Expanding the Role of Retail Health Clinics in...

The National Coalition for Sexual Health, in partnership with the Convenient...

Jun 11, 2021 | Shalesha Majors

Expanding the Role of Retail Health Clinics in...

Back to Top